These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17302677)

  • 21. [Treatment of silicosis complicated with chronic obstructive pulmonary disease in 38 cases].
    Li HL; Tang ZQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Aug; 29(8):617-8. PubMed ID: 22335166
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-Inflammatory Effects of Japanese Herbal Medicine Hochuekkito in a Mouse Model of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Fukuda K; Matsuzaki H; Hiraishi Y; Miyashita N; Ishii T; Yuki M; Isago H; Tamiya H; Mitani A; Saito A; Jo T; Nagase T
    Pharmacology; 2024; 109(2):121-126. PubMed ID: 38346407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in the study of Allium macrostemon Bunge].
    Zhang Q; Gao E
    Zhongguo Zhong Yao Za Zhi; 2003 Feb; 28(2):105-7. PubMed ID: 15015277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
    Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
    Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Japanese Herbal (Kampo) Medicine Hochuekkito Attenuates Lung Inflammation in Lung Emphysema.
    Isago H; Mitani A; Kohno S; Nagoshi S; Ishimori T; Saito M; Tamiya H; Miyashita N; Ishii T; Matsuzaki H; Yatomi Y; Nagase T; Jo T
    Biol Pharm Bull; 2021; 44(1):39-45. PubMed ID: 33390548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B].
    Wang SL; Yao NL; Lv WL
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2468-70. PubMed ID: 18330233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro and in a collagen-induced arthritis model.
    Chang SH; Choi Y; Park JA; Jung DS; Shin J; Yang JH; Ko SY; Kim SW; Kim JK
    Clin Nutr; 2007 Dec; 26(6):785-91. PubMed ID: 17933436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on treatment of chronic obstructive pulmonary disease in stable stage by bufei yishen recipe].
    Wang KG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jun; 24(6):555-6. PubMed ID: 15250216
    [No Abstract]   [Full Text] [Related]  

  • 32. [Traditional Chinese medicine therapy of secondly hypoxia pulmonary arterial hypertension caused by chronic obstructive pulmonary diseases].
    Jiao L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Nov; 20(11):867-8. PubMed ID: 11938837
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.
    Loza MJ; Watt R; Baribaud F; Barnathan ES; Rennard SI
    Respir Res; 2012 Feb; 13(1):12. PubMed ID: 22300528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease].
    He P
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2089-91. PubMed ID: 19080465
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of expired air moisture condensate in assessment of pulmonary inflammation in patients with chronic obstructive pulmonary disease].
    Dotsenko EK; Goncharova VA; Kuzubova NA; Kamenova MIu; Egorova NV
    Ter Arkh; 2008; 80(3):10-4. PubMed ID: 18441676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluticasone reduces CRP in COPD.
    Virchow JC
    Am J Respir Crit Care Med; 2005 May; 171(10):1191; author reply 1191-2. PubMed ID: 15879429
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammatory response to exercise in COPD.
    Canavan J; Robson-Ansley P; Garrod R; Jewell A
    Respir Med; 2006 Jun; 100(6):1125-6; author reply 1127. PubMed ID: 16616482
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.
    Mroz RM; Holownia A; Chyczewska E; Braszko JJ
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation in chronic heart failure.
    Parish RC; Evans JD
    Ann Pharmacother; 2008 Jul; 42(7):1002-16. PubMed ID: 18477736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.